Drug profile · INN
sodium phenylbutyrate
PHEBURANE
sodium phenylbutyrate (PHEBURANE) is a glutamine sequestering agent. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — sodium phenylbutyrate
- US status
- approved
- Class
- Alimentary tract and metabolism (A16)
- Route
- ORAL
- Patents
- 5
- Programs
- 3
- Data quality
- 0.89
Quick answer
sodium phenylbutyrate (PHEBURANE) is a glutamine sequestering agent. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Glutamine sequestering agent
Primary target: Glutamine
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 11583542
Compositions of bile acids and phenylbutyrate compounds
granted -
US 11071742
Compositions for improving cell viability and methods of use thereof
granted -
US 10857162
Compositions for improving cell viability and methods of use thereof
granted -
US 10251896
Compositions for improving cell viability and methods of use thereof
granted -
US 9872865
Compositions for improving cell viability and methods of use thereof
granted
Frequently asked questions
What is sodium phenylbutyrate?
sodium phenylbutyrate (PHEBURANE) is a glutamine sequestering agent. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sodium phenylbutyrate?
PHEBURANE is a marketed brand name for sodium phenylbutyrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sodium phenylbutyrate?
sodium phenylbutyrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.